Rothschild Investment LLC Inmune Bio, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 30 shares of INMB stock, worth $231. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 30
-0.0%
Holding current value
$231
Previous $140,000
67.14%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding INMB
# of Institutions
81Shares Held
7.08MCall Options Held
202KPut Options Held
42.9K-
Black Rock Inc. New York, NY813KShares$6.26 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR812KShares$6.25 Million1.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA738KShares$5.68 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$4.59 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL476KShares$3.66 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $138M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...